Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
More in Startups
Figma announces new features to define how agents work on its platform
October 15, 2026
Ricursive Intelligence is betting on AI-designed chips to help solve the compute crisis
October 15, 2026
Flock CEO defends surveillance technology amid national backlash: ‘We shouldn’t pause progress’
October 15, 2026
Meet the five companies competing in the Startup Battlefield finals at Disrupt 2026
October 15, 2026
Gudea leverages AI to help organizations prevent social media crises before they erupt
October 15, 2026
CedarDB wants one database to handle both transactions and analytics, as AI agents raise the stakes
October 14, 2026
Latest News
BSA Gold Star 650 gets two new colours
October 15, 2026
What to expect from the new Audi Q3 ahead of launch tomorrow
October 15, 2026
Updated Bajaj Pulsar NS160 spotted testing
October 15, 2026
Mahindra XUV 3XO CNG vs rivals: price, specifications compared
October 15, 2026
BS7 emission norms rollout proposed from April 2029: Report
October 15, 2026
Mahindra XUV 3XO CNG launched at Rs 9.99 lakh
October 15, 2026